Literature DB >> 7981593

Cognitive impairment in Duchenne muscular dystrophy.

N Bresolin1, E Castelli, G P Comi, G Felisari, A Bardoni, D Perani, F Grassi, A Turconi, F Mazzucchelli, D Gallotti.   

Abstract

Cognitive function and dystrophin gene mutations were investigated in 50 DMD patients (mean age 11.1 yr; range 3.5-20.3). General intelligence assessment showed 31% of patients with Wechsler full intelligence quotient (FIQ) lower than 75 (normal values: 100 +/- 14), and only 24% with appropriate FIQ level. Modal distribution of Wechsler verbal, performance, and FIQs, and Raven IQs was normal. Verbal IQ was more affected than performance IQ (PIQ) only in the younger group of subjects. Low PIQ correlated with the presence of macroglossia, detected in 13 out of 50 patients. Impairment of productive language was of non-dysphasic nature and correlated with defects of short-term memory, which was also affected in non-verbal skills. DMD patients shared the same spectrum of neuropsychological defects, regardless of whether they were or were not mentally retarded. The proportion of patients with dystrophin gene deletions was 64%. No statistically significant correlations were found between genetic data and psychometric assessment. Finally, (18F)-fluorodeoxyglucose positron emission tomography studies demonstrated cerebellar hypometabolism in all the DMD patients examined and variable involvement of associative cortical areas. These findings suggest a possible role of the cerebral and cerebellar hypometabolism in the cognitive impairment of DMD.

Entities:  

Mesh:

Year:  1994        PMID: 7981593     DOI: 10.1016/0960-8966(94)90072-8

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  37 in total

1.  Two children with muscular dystrophies ascertained due to referral for diagnosis of autism.

Authors:  Lonnie Zwaigenbaum; Mark Tarnopolsky
Journal:  J Autism Dev Disord       Date:  2003-04

Review 2.  The muscular dystrophies: from genes to therapies.

Authors:  Richard M Lovering; Neil C Porter; Robert J Bloch
Journal:  Phys Ther       Date:  2005-12

Review 3.  Dystrophin Dp71: the smallest but multifunctional product of the Duchenne muscular dystrophy gene.

Authors:  Ramin Tadayoni; Alvaro Rendon; L E Soria-Jasso; Bulmaro Cisneros
Journal:  Mol Neurobiol       Date:  2011-11-22       Impact factor: 5.590

4.  Decreased gray matter concentration and local synchronization of spontaneous activity in the motor cortex in Duchenne muscular dystrophy.

Authors:  S-Y Lv; Q-H Zou; J-L Cui; N Zhao; J Hu; X-Y Long; Y-C Sun; J He; C-Z Zhu; Y He; Y-F Zang
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-29       Impact factor: 3.825

5.  Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy.

Authors:  Bo Deng; David Glanzman; James G Tidball
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

6.  Longing: the lived experience of spirituality in adolescents with Duchenne muscular dystrophy.

Authors:  Shelley-Rae Pehler; Martha Craft-Rosenberg
Journal:  J Pediatr Nurs       Date:  2009-05-26       Impact factor: 2.145

7.  Diffusion tensor imaging study in Duchenne muscular dystrophy.

Authors:  Ya Fu; Yuru Dong; Chao Zhang; Yu Sun; Shu Zhang; Xuetao Mu; Hong Wang; Weihai Xu; Shiwen Wu
Journal:  Ann Transl Med       Date:  2016-03

8.  Profound human/mouse differences in alpha-dystrobrevin isoforms: a novel syntrophin-binding site and promoter missing in mouse and rat.

Authors:  Sabrina V Böhm; Panayiotis Constantinou; Sipin Tan; Hong Jin; Roland G Roberts
Journal:  BMC Biol       Date:  2009-12-04       Impact factor: 7.431

Review 9.  The roles of the dystrophin-associated glycoprotein complex at the synapse.

Authors:  Gonneke S K Pilgram; Saranyapin Potikanond; Richard A Baines; Lee G Fradkin; Jasprina N Noordermeer
Journal:  Mol Neurobiol       Date:  2009-11-09       Impact factor: 5.590

10.  Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy.

Authors:  Peter J Taylor; Grant A Betts; Sarah Maroulis; Christian Gilissen; Robyn L Pedersen; David R Mowat; Heather M Johnston; Michael F Buckley
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.